Information Provided By: 
Fly News Breaks for July 8, 2019
BHC
Jul 8, 2019 | 05:59 EDT
Barclays analyst Balaji Prasad reiterates an Overweight rating on Bausch Health Companies with a $28 price target saying the company's fundamentals are continuing to improve. The shares have gained nearly 20% in the month of June alone, and "steady" execution on both the balance sheet and business "will sustain this outperformance," Prasad tells investors in a research note. He believes Xifaxan demand remains "healthy" and that the June launches of Duobrii and ULTRA Multifocal Lenses support his longer-term growth forecast.
News For BHC From the Last 2 Days
There are no results for your query BHC
